Literature DB >> 2195985

Epidermal growth factor receptors in colorectal carcinoma.

M Moorghen1, P Ince, K J Finney, A J Watson, A L Harris.   

Abstract

Nineteen samples of primary colorectal carcinoma and adjacent mucosa were examined for EGFr expression using radioligand binding assays and immunohistochemical staining with the monoclonal antibody EGFR1. Radioligand binding experiments showed expression of EGFr in both tumour and mucosa in all cases. In tumour samples EGFr levels ranged between 4 and 79 fmole per mg membrane protein (Kd = 0.1-0.4 X 10(-9) M). There was no significant difference in the level of EGFr expression between tumour and mucosa overall. Immunohistochemical staining with the EGFR1 antibody was useful in localising EGFr to epithelial elements although it was less sensitive than ligand binding assays.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2195985

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

Review 1.  Vaccine strategies for glioblastoma: progress and future directions.

Authors:  Christopher Jackson; Jacob Ruzevick; Henry Brem; Michael Lim
Journal:  Immunotherapy       Date:  2013-02       Impact factor: 4.196

2.  Differential expression of epidermal growth factor-related proteins in human colorectal tumors.

Authors:  F Ciardiello; N Kim; T Saeki; R Dono; M G Persico; G D Plowman; J Garrigues; S Radke; G J Todaro; D S Salomon
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

3.  Effects of epidermal growth factor and its signal transduction inhibitors on apoptosis in human colorectal cancer cells.

Authors:  Jane C J Chao; Wen Li Peng; Sheng-Hsuan Chen
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

4.  Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis.

Authors:  Alexander A Parikh; Fan Fan; Wen Biao Liu; Syed A Ahmad; Oliver Stoeltzing; Niels Reinmuth; Diane Bielenberg; Corazon D Bucana; Michael Klagsbrun; Lee M Ellis
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

5.  Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon.

Authors:  G R Johnson; T Saeki; A W Gordon; M Shoyab; D S Salomon; K Stromberg
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

6.  Molecular determination of epidermal growth factor receptor in normal and neoplastic colorectal mucosa.

Authors:  G Piazzi; P Paterini; C Ceccarelli; M A Pantaleo; G Biasco
Journal:  Br J Cancer       Date:  2006-10-31       Impact factor: 7.640

7.  A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.

Authors:  I Zlobec; T Vuong; S Hayashi; D Haegert; L Tornillo; L Terracciano; A Lugli; J Jass
Journal:  Br J Cancer       Date:  2007-02-20       Impact factor: 7.640

8.  Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system.

Authors:  Marta Rokita; Rafał Stec; Lubomir Bodnar; Radosław Charkiewicz; Jan Korniluk; Marta Smoter; Marzena Cichowicz; Lech Chyczewski; Jacek Nikliński; Wojciech Kozłowski; Cezary Szczylik
Journal:  Onco Targets Ther       Date:  2013-07-24       Impact factor: 4.147

9.  Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue.

Authors:  P G Koenders; W H Peters; T Wobbes; L V Beex; F M Nagengast; T J Benraad
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.